InsiderClue
Insiders · Profile

Clague Laura

Chief Financial Officer at Travere Therapeutics · Director at Genasys. Filing since 11 Dec 2008. CIK 0001388773

TVTX Travere Therapeutics, Inc. Chief Financial Officer · 29 trades GNSS Genasys Inc. Director · 4 trades
Company
Date
Role
Action
Shares
Amount
Of holding
TVTX Travere Therapeutics, Inc.
11 May 2022
Chief Financial Officer
Sold, plan not stated
1,375
$29.58K
3.7%
TVTX Travere Therapeutics, Inc.
10 May 2022
Chief Financial Officer
Sold, plan not stated
825
$17.75K
2.2%
GNSS Genasys Inc.
23 Feb 2022
Director
Sold, plan not stated
13,716
$43.07K
6.3%
TVTX Travere Therapeutics, Inc.
31 Jan 2022
Chief Financial Officer
Sold, plan not stated
1,238
$33.92K
3.2%
TVTX Travere Therapeutics, Inc.
24 Jan 2022
Chief Financial Officer
Sold, plan not stated
2,063
$51.53K
6.6%
TVTX Travere Therapeutics, Inc.
11 Jan 2022
Chief Financial Officer
Sold, plan not stated
7,500
$205.50K
19.3%
TVTX Travere Therapeutics, Inc.
17 Aug 2021
Chief Financial Officer
Sold, plan not stated
1,407
$24.09K
4.3%
TVTX Travere Therapeutics, Inc.
12 May 2021
Chief Financial Officer
Sold, plan not stated
2,000
$38.92K
6.6%
TVTX Travere Therapeutics, Inc.
11 May 2021
Chief Financial Officer
Sold, plan not stated
2,000
$38.28K
6.2%
GNSS Genasys Inc.
10 Mar 2021
Director
Sold, plan not stated
5,456
$40.46K
3.1%
TVTX Travere Therapeutics, Inc.
8 Feb 2021
Chief Financial Officer
Sold, plan not stated
2,250
$71.06K
6.5%
TVTX Travere Therapeutics, Inc.
5 Feb 2021
Chief Financial Officer
Sold, plan not stated
2,250
$70.67K
6.1%
TVTX Travere Therapeutics, Inc.
3 Feb 2021
Chief Financial Officer
Sold, plan not stated
3,625
$104.80K
10.1%
TVTX Travere Therapeutics, Inc.
2 Feb 2021
Chief Financial Officer
Sold, plan not stated
3,625
$111.47K
9.2%
TVTX Travere Therapeutics, Inc.
25 Nov 2020
Chief Financial Officer
Sold, plan not stated
3,750
$85.20K
16.1%
TVTX Travere Therapeutics, Inc.
24 Nov 2020
Chief Financial Officer
Sold, plan not stated
3,750
$89.48K
13.9%
TVTX Travere Therapeutics, Inc.
16 Nov 2020
Chief Financial Officer
Sold, plan not stated
7,500
$179.81K
27.8%
TVTX Travere Therapeutics, Inc.
13 Nov 2020
Chief Financial Officer
Sold, plan not stated
7,500
$177.07K
21.8%
TVTX Travere Therapeutics, Inc.
23 Sep 2020
Chief Financial Officer
Sold, plan not stated
1,500
$27.72K
7.2%
TVTX Travere Therapeutics, Inc.
22 Sep 2020
Chief Financial Officer
Sold, plan not stated
1,500
$27.89K
6.7%
TVTX Travere Therapeutics, Inc.
12 May 2020
Chief Financial Officer
Sold, plan not stated
1,777
$30.40K
8.4%
TVTX Travere Therapeutics, Inc.
11 May 2020
Chief Financial Officer
Sold, plan not stated
1,250
$18.69K
5.6%
TVTX Travere Therapeutics, Inc.
10 Mar 2020
Chief Financial Officer
Sold, plan not stated
4,000
$60.08K
15.1%
TVTX Travere Therapeutics, Inc.
16 May 2019
Chief Financial Officer
Sold, plan not stated
1,250
$23.39K
8.5%
TVTX Travere Therapeutics, Inc.
15 May 2019
Chief Financial Officer
Sold, plan not stated
1,250
$22.23K
7.8%
TVTX Travere Therapeutics, Inc.
12 Feb 2019
Chief Financial Officer
Sold, plan not stated
1,016
$21.84K
9.2%
TVTX Travere Therapeutics, Inc.
11 Feb 2019
Chief Financial Officer
Sold, plan not stated
1,017
$21.74K
8.5%
TVTX Travere Therapeutics, Inc.
21 Dec 2018
Chief Financial Officer
Sold, plan not stated
3,750
$81.86K
23.8%
TVTX Travere Therapeutics, Inc.
20 Dec 2018
Chief Financial Officer
Sold, plan not stated
3,750
$82.80K
19.2%
TVTX Travere Therapeutics, Inc.
15 Nov 2018
Chief Financial Officer
Sold, plan not stated
3,750
$91.17K
23.8%
TVTX Travere Therapeutics, Inc.
14 Nov 2018
Chief Financial Officer
Sold, plan not stated
3,750
$88.97K
19.2%
GNSS Genasys Inc.
4 Sep 2013
Director
Sold, plan not stated
9,400
$14.48K
29.4%
GNSS Genasys Inc.
11 Dec 2008
Director
Bought
2,000
$870.00
opened
33 decisions on file.